NEWSROOMVoices Saniona begins 2022 with three clinical trials ongoingJanuary 4, 2022 | BioStock The Potential Of Ion Channel-Based TherapeuticsSeptember 8, 2021 | Cell & Gene Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic ObesityAugust 19, 2021 | Health Professional Radio [ENG]
Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic ObesityAugust 19, 2021 | Health Professional Radio [ENG]
